HIV
A case study from the Tianjin Centers for Disease Control and Prevention in China has revealed that improper use of pre-exposure prophylaxis (PrEP) can lead to breakthrough infections and diagnostic challenges. Despite the high efficacy of PrEP in preventing HIV infection among men who have sex with men (MSM), the
HIV
Researchers from the University of Miami have made significant progress in the development of a new approach for preventing and treating HIV infection. The study, published in Nature Communications, presented a promising method of using adeno-associated virus (AAV) vector to deliver broadly neutralizing antibodies (bnAbs) for long-term HIV prevention and
HIV
Young men who have sex with men (YMSM) in Taiwan are disproportionately at risk for HIV infection, with limited knowledge about their intention to use oral rapid self-testing (ORST) for HIV. A recent study conducted by researchers from the National Taiwan University found that YMSM in Taiwan have a higher
HIV
Research conducted by Banu Humeyra Keskin and colleagues at the Zonguldak Gynecology and Pediatrics Hospital in Turkey has investigated the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections among healthcare workers in the hospital. The study retrospectively analyzed the records of 364
HIV
A recent study has shed light on changes in body mass index (BMI), systolic and diastolic blood pressure (SBP and DBP), and lipid profile in patients initiating efavirenz/tenofovir disoproxil fumarate/emtricitabine (EFV/TDF/FTC) or dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) antiretroviral therapy (ART) regimens during acute HIV infection
HIV infections
A case study from the Tianjin Centers for Disease Control and Prevention in China has revealed that improper use of pre-exposure prophylaxis (PrEP) can lead to breakthrough infections and diagnostic challenges. Despite the high efficacy of PrEP in preventing HIV infection among men who have sex with men (MSM), the
HIV
Fresh data on the association between HIV infection and the risk of long COVID has been presented in a new report. Research from the University of Missouri and the National Institutes of Health has found that people with HIV may be at increased risk for long COVID after acute SARS-CoV-2
HIV
Cambodia has made significant strides in its HIV response by becoming the first country in Asia and the Pacific to integrate both CAB-LA (long-acting injectable PrEP) and the dapivirine vaginal ring into its public health system. This historic move marks a major advancement in HIV prevention for women, offering a
HIV infections
The US State Department is making a significant investment in the global battle to stop the spread of AIDS, announcing it will work with a pharmaceutical company and the global fund to procure a new HIV prevention drug dubbed a "game-changer." This new drug, lenacapavir, has shown almost
HIV
A recent study published in the Lancet HIV has shed light on the effectiveness of pre-exposure prophylaxis (PrEP) medications in preventing new HIV infections. The research, conducted by a team of scientists at Emory University, analyzed data from a nationwide commercial pharmacy database and public health surveillance data to assess
HIV
Cambodia may struggle to meet its goal of reducing new HIV infections to less than one person per day by 2030, with the current rate sitting at over three people per day. The National AIDS Authority (NAA) has set a target to decrease the number of new HIV infections from
HIV infections
Cambodia is making significant strides in combating HIV/AIDS, with the country ranked 11th out of 196 globally in its efforts, as per a senior government official. Ieng Mouly, Chair of the National Aids Authority (NAA), highlighted Cambodia's progress while addressing the 54th UNAIDS Programme Coordinating Board (PCB)
